Next steps and support
ADHD medication for children: role, follow-up, and parents' questions
ADHD medication often raises legitimate questions: what is it for, when might it be discussed, what is monitored, and how can you talk about it with your child? Clear information helps avoid both trivialization and excessive worry.
When medication is considered, it forms part of comprehensive care and medical follow-up. The doctor assesses the situation, discusses goals, and organizes monitoring with the child and parents.
This guide explains the role of follow-up without providing dosages, recommending a drug, or promising effectiveness for a particular child.

Medication and follow-up
Medical follow-up brings together observations from the child, family, and relevant professionals.
A possible role within comprehensive support
Medication is not an automatic response to every difficulty with attention, restlessness, or impulsivity. Its possible role is discussed after assessment, according to impact, intended goals, and the child's context.
It does not replace other useful supports: information, family support, school, or psychological or rehabilitative interventions that address an identified need. Approaches can complement one another without competing.
Prescribing and follow-up: an individualized medical framework
The exact arrangements for prescribing, adjusting, and renewing medication are medical and regulated. They cannot be replaced by a guide's general information.
A shared medical decision
The doctor explains the proposal, checks relevant medical information, and discusses expected benefits and precautions with the child and legal guardians.
Goals observed over time
Follow-up considers effects on the agreed goals, without relying solely on a score or one easier or harder day.
Observations that support follow-up
Parents and children can report perceived changes, difficulties, or questions for discussion with the relevant professional.
What medication is expected to do—and what it is not
When medication is proposed, the aim is to reduce a significant impact on targets defined with the child and family. It should not make the child silent, change their personality, or replace educational adjustments. A favorable response may make some activities easier, but it does not automatically resolve a learning difficulty, conflict, or associated anxiety.
The decision follows a clinical assessment and discussion of options. French recommendations place medication within a comprehensive plan and combine it with non-medication measures. The child's preferences, concerns, and voice should be heard in an age-appropriate way.
Follow-up compares benefits and adverse effects in everyday life
The professional organizes monitoring of effectiveness, appetite, growth, sleep, heart rate, blood pressure, and reported effects according to the treatment and situation. Parents can record concrete observations—time of day, task, eating, falling asleep—without interpreting their causes themselves.
A troublesome effect, lack of benefit, or difficulty taking medication should be reported to the prescriber. Do not change the dose, timing, formulation, or stop treatment based on an article or informal advice. For an acute concerning reaction, promptly contact a professional or emergency services according to severity.
Measures monitored according to the situation
Monitoring supports safe, proportionate adjustments to care. It does not mean every child will experience the same effects or that an effect is inevitable.
- The intended benefits in the child's daily life
- Appetite, sleep, mood, or any change noticed by the child or family
- Height, weight, and growth when the professional considers them relevant
- Other health measures and existing treatments, according to the clinical situation
- How the child experiences treatment and what they wish to say about it
Discuss questions and misconceptions with the child's professional
Questions about medication can be raised without shame: goals, hoped-for benefits, concerns, observed effects, and arrangements at school or home. Teenagers, when relevant, should also be able to express their perspective.
No relative, forum, or guide can replace the doctor in changing how medication is taken, stopping treatment, or choosing another option. If in doubt, contact the professional caring for the child or a pharmacist.
Cereya ADHD
Prepare questions for your child's follow-up
Cereya's child ADHD assessment can help organize everyday observations before a consultation.
It provides no dosages, recommends no medication, and never replaces instructions from a doctor or pharmacist.
- assessment supported by a parent or legal guardian
- questions for the parent and child
- brief attention exercises adapted to age
- informative report with points requiring caution
- no medical diagnosis
Initial summary included; detailed analysis available afterward.

Medication and follow-up
Medical follow-up brings together observations from the child, family, and relevant professionals.
FAQ
Frequently asked questions
Is medication always used for ADHD?+
Medication may be considered in some situations within comprehensive care. Its role depends on clinical assessment, the child's difficulties, expected benefits, and other supports already discussed. It is not automatic.
Who decides on medication?+
Prescribing and adjustments are the responsibility of the child's doctor, within the applicable regulatory framework. Parents and children can ask why treatment is being proposed, what goals it targets, and how follow-up will be organized.
What does the doctor monitor?+
Follow-up addresses the intended benefits and any difficulties or adverse effects. Depending on the situation, the professional may monitor growth, appetite, sleep, weight, height, or other relevant measures.
Why is follow-up individualized?+
Responses to treatment, like children's needs, vary. Regular follow-up allows discussion and adjustments to care if needed. Comparing the child with other families or isolated accounts is not useful.
Can you change or stop treatment yourself?+
No. Treatment must never be started, changed, stopped, or shared without medical advice. For a question, difficulty, or unusual effect, contact the professional caring for the child or seek advice from a pharmacist as appropriate.
References and resources
These institutional sources present the general framework for prescribing and monitoring ADHD medication in children. They do not replace individualized advice from the prescribing doctor or pharmacist.
- Haute Autorité de Santé (2024) — ADHD: recommendations and medication monitoring form for children.
- Assurance Maladie — Attention deficit and/or hyperactivity: what treatment?
- ANSM — Methylphenidate: usage data and monitoring of height, weight, and appetite.
- NICE guideline NG87 — Monitoring effectiveness, adverse effects, growth, and sleep.
- Cortese, S., Adamo, N., Del Giovane, C., et al. (2018). Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. The Lancet Psychiatry, 5(9), 727–738. DOI: 10.1016/S2215-0366(18)30269-4. PMID: 30097390.
Explore further